BLND Stock Cash Flow Statements

Blend Labs Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Blend Labs Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30

operating activities
net income	-6,645,000	-9,412,000	-708,000	-2,627,000	-19,421,000	-20,663,000	-30,376,000	-41,820,000	-41,489,000	-66,194,000	-132,747,000	-477,202,000	-72,418,000	-71,511,000	-76,330,000
less: net income from discontinued operations	-2,998,000	-2,803,000
income from continuing operations	-3,647,000	-6,609,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation	7,562,000	6,048,000	6,064,000	6,671,000	7,271,000	8,071,000	6,223,000	9,042,000	14,364,000	16,392,000	27,951,000	29,248,000	24,312,000	16,795,000	43,424,000
depreciation and amortization	640,000	407,000	486,000	681,000	558,000	564,000	608,000	600,000	626,000	630,000	929,000	4,623,000	4,601,000	3,842,000	5,111,000
amortization of deferred contract costs	431,000	315,000	289,000	260,000	253,000	266,000	552,000	682,000	761,000	984,000	1,133,000	1,183,000	1,244,000	1,174,000	1,245,000
amortization of debt discount and issuance costs			0	0	170,000	520,000	689,000	790,000	759,000	730,000	747,000	731,000	709,000	706,000
amortization of operating lease right-of-use assets	122,000	77,000	196,000	631,000	842,000	861,000	846,000	835,000	809,000	806,000	1,025,000	851,000	785,000	956,000	1,116,000
gain on investment in equity securities			0	0	0	-4,417,000
loss on extinguishment of debt			0	0
other	-178,000	-138,000	-324,000	-359,000	-92,000	-234,000	-530,000	-1,285,000	-2,025,000	-1,347,000	501,000	410,000	1,049,000	1,628,000	487,000
changes in operating assets and liabilities:
trade and other receivables	-4,270,000	3,906,000	-1,476,000	3,621,000	-1,409,000	182,000	1,245,000	1,709,000	-1,580,000	2,900,000	3,423,000	3,330,000	409,000	-3,778,000	-163,000
prepaid expenses and other assets, current and non-current	-1,651,000	389,000	-857,000	-3,656,000	2,486,000	967,000	3,544,000	2,415,000	1,058,000	-4,969,000	-4,173,000	5,167,000	2,830,000	4,257,000	-11,282,000
deferred contract costs, non-current	-178,000	-353,000	-805,000	-43,000	177,000	256,000	-220,000	234,000	-993,000	217,000	701,000	669,000	852,000	-875,000	636,000
accounts payable	-1,465,000	1,046,000	554,000	868,000	-1,217,000	-272,000	49,000	-1,028,000	1,217,000	672,000	-752,000	1,456,000	-4,314,000	-625,000	512,000
deferred revenue	-520,000	13,254,000	-617,000	-975,000	-708,000	12,556,000	-1,072,000	-1,914,000	-1,076,000	4,351,000	-2,087,000	-2,126,000	6,104,000	-1,960,000	-1,450,000
accrued compensation	-1,195,000	511,000	-2,405,000	2,783,000	-1,961,000	-376,000	-4,305,000	5,126,000	-6,294,000	976,000	4,177,000	-3,913,000	-4,651,000	4,638,000	-422,000
operating lease liabilities	-974,000	-947,000	-1,393,000	-1,046,000	-1,096,000	-1,050,000	-1,068,000	-1,027,000	-914,000	-1,003,000	-822,000	-883,000	-958,000	-1,049,000	-876,000
other liabilities, current and non-current	31,000	2,179,000	-3,590,000	1,488,000	2,005,000	-1,099,000	-846,000	-246,000	387,000	-1,798,000	-5,464,000	-2,125,000	-3,532,000	-4,522,000	6,029,000
net cash from operating activities - continuing operations	-5,292,000	20,085,000
net cash from operating activities - discontinued operations	-1,076,000	305,000
net cash from operating activities	-6,368,000	20,390,000	-4,586,000	2,076,000	-6,666,000	-3,868,000	-20,691,000	-25,887,000	-34,390,000	-46,653,000	-50,485,000	-46,758,000	-45,842,000	-43,124,000	-31,279,000
capex	-327,000	528,000	-264,000	0	0	0	0	0	0	0	-446,000	-896,000	-268,000	-649,000	-560,000
free cash flows	-6,695,000	20,918,000	-4,850,000	2,076,000	-6,666,000	-3,868,000	-20,691,000	-25,887,000	-34,390,000	-46,653,000	-50,931,000	-47,654,000	-46,110,000	-43,773,000	-31,839,000
investing activities
purchases of marketable securities	-11,873,000	-11,876,000	-5,608,000	-19,893,000	-28,217,000	-48,312,000	-32,798,000	-8,324,000	-8,751,000	-186,206,000	-46,463,000	-19,305,000	-30,450,000	-34,764,000	-267,967,000
sale of available-for-sale securities	11,000	848,000	0	30,000	0	100,297,000
maturities of marketable securities	8,800,000	18,927,000	11,300,000	26,250,000	5,000,000	10,600,000	32,595,000	80,146,000	40,139,000	157,570,000	78,096,000	31,741,000	30,035,000	16,393,000	33,850,000
investment in non-marketable equity securities														0
additions to property, equipment and internal-use software development costs	-3,733,000	-4,587,000	-2,581,000
net cash from investing activities - continuing operations	-10,795,000	3,312,000
net cash from investing activities - discontinued operations	-36,000	-84,000
net cash provided (used in) by investing activities
financing activities
proceeds from exercises of stock options, including early exercises, net of repurchases	430,000	363,000	789,000	155,000	95,000	619,000	248,000	-2,000	1,000	21,000	940,000	428,000	1,202,000
taxes paid related to net share settlement of equity awards	-2,531,000	-2,971,000	-7,112,000	-3,984,000	-3,213,000	-3,806,000	-1,314,000	-1,325,000	-1,092,000	-2,440,000
share repurchases	-1,550,000	-2,568,000
repayment of long-term debt			0	0
net proceeds from the issuance of the series a redeemable convertible preferred stock and the haveli warrant
payment for issuance costs related to the series a redeemable convertible preferred stock and the haveli warrant
net cash from financing activities - continuing operations	-3,651,000	-5,176,000
effect of exchange rates on cash, cash equivalents, and restricted cash			0	0	-1,000	-4,000		-23,000	5,000	8,000	55,000	77,000	28,000
net increase in cash, cash equivalents, and restricted cash	-20,850,000	18,442,000	-12,798,000	9,591,000	-39,071,000	53,562,000					-18,303,000	-34,983,000	-45,416,000	-63,230,000	-93,413,000
cash, cash equivalents, and restricted cash at beginning of period	0	49,537,000	0	0	0	38,253,000	0	0	0	129,557,000	0	0	218,440,000	0	0
cash, cash equivalents, and restricted cash at end of period	-20,850,000	67,979,000	-12,798,000	9,591,000	-39,071,000	91,815,000	-53,596,000	44,554,000	-4,258,000	51,553,000	-18,303,000	-34,983,000	173,024,000	-63,230,000	-93,413,000
less: cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations	-1,105,000	6,712,000
cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations	-19,745,000	61,267,000
reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets:
cash and cash equivalents	-19,745,000	56,244,000	-12,798,000	9,591,000	-39,071,000	84,521,000	-53,593,000	49,575,000	-11,215,000	46,195,000	-18,303,000	-34,983,000	167,666,000	-62,981,000	-93,663,000
restricted cash	0	5,023,000	0	0	0	7,294,000	-3,000	-5,021,000	6,957,000	5,358,000	0	0	5,358,000	-249,000	250,000
total cash, cash equivalents, and restricted cash	-19,745,000	61,267,000	-12,798,000	9,591,000	-39,071,000	91,815,000	-53,596,000	44,554,000	-4,258,000	51,553,000	-18,303,000	-34,983,000	173,024,000	-63,230,000	-93,413,000
supplemental disclosure of cash flow information:
cash paid for income taxes	199,000	133,000	0	0	67,000	9,000		0	-53,000	101,000			11,000	394,000	445,000
cash paid for interest			0	0	1,621,000	4,529,000		7,364,000	7,189,000	6,911,000			4,944,000
supplemental disclosure of non-cash investing and financing activities:
reclassification of redeemable noncontrolling interest related to discontinued operations to equity	0	52,675,000
vesting of early exercised stock options			0	7,000	172,000	184,000		230,000	256,000	758,000			1,913,000	1,677,000	1,809,000
operating lease liabilities arising from obtaining new or modified right-of-use assets			0	497,000	0	654,000		0	0	327,000
stock-based compensation included in capitalized internal-use software development costs	1,127,000	1,218,000	509,000	811,000	494,000	636,000
accretion of redeemable noncontrolling interest related to discontinued operations to redemption value	0	1,254,000
accretion of series a redeemable convertible preferred stock to redemption value	4,376,000	4,202,000	4,170,000	4,048,000
capitalized internal-use software development costs included in accrued compensation	-327,000	528,000	-264,000
issuance costs accrued in connection with the series a redeemable convertible preferred stock and the warrant
net cash from investing activities		3,228,000	-1,889,000	11,747,000	-25,084,000	60,621,000	53,237,000	71,791,000	31,218,000	-28,940,000	31,187,000	11,540,000	-683,000	-19,172,000	-654,025,000
impairment of intangible assets and goodwill											57,857,000
accelerated amortization of right-of-use asset in connection with lease abandonment			0
gain on sale of insurance business			0
release of valuation allowance and change in deferred taxes											0	0	-2,864,000	7,200,000	0
proceeds from sale of insurance business			0
investment in note receivable														0
proceeds from initial public offering, net of underwriters' fees and issuance costs														-2,048,000
net cash from financing activities			-6,323,000	-4,232,000	-7,320,000	-3,187,000	-86,121,000	-1,327,000	-1,091,000	-2,419,000	940,000	158,000	1,081,000	-925,000	591,891,000
reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets:
accretion of redeemable noncontrolling interest to redemption value			1,511,000	1,760,000	1,527,000	1,461,000		1,452,000	1,592,000	2,056,000			1,442,000
covered warrant received in connection with strategic partnership and sale of insurance business
net proceeds from the issuance of the series a redeemable convertible preferred stock and the warrant				0
payment for issuance costs related to the series a redeemable convertible preferred stock and the warrant				-403,000
warrant received in connection with strategic partnership and sale of insurance business
accrual of transaction costs incurred in connection with sale of insurance business
additions to property, equipment, internal-use software development costs and intangible assets					-1,867,000	-1,964,000
sale of marketable securities
additions to property, equipment, internal-use software and intangible assets							-82,000	-31,000	-170,000	-304,000
acquisition of title365, net of cash acquired														0
proceeds from debt financing, net of issuance costs														-24,000
partial repayment of long-term debt principal
proceeds from issuance of convertible preferred stock, net of issuance costs														0	0
proceeds from exercises of convertible preferred stock warrants														0	0
proceeds from repayment of employee promissory note collateralized by common stock														0
effect of exchange rates on cash, cash equivalents and restricted cash
payment of initial public offering costs												-270,000	-121,000
net decrease in cash, cash equivalents, and restricted cash								44,554,000	-4,258,000	-78,004,000
purchases of property and equipment											-446,000	-896,000	-268,000	-649,000	-560,000
purchase of other investment
cash acquired in connection with business combination
payment of debt issuance costs
right-of-use assets obtained in exchange for lease obligations													317,000
interest on discount on convertible note
sales of marketable securities
capitalization of internal-use software
purchases of intangible assets
repurchases of unvested early exercised stock options														-110,000	-10,000
proceeds from exercises of stock options, including early exercises														1,257,000	708,000
proceeds from exercises of common stock warrants
proceeds from convertible debt
proceeds from exercises of series d convertible preferred stock warrants
non-cash additions to property and equipment
issuance of warrant in connection with debt financing														0
exercise of series d convertible preferred stock warrants included in prepaid expenses and other current assets
deferred offering costs not yet paid															-2,661,000
payment of deferred offering costs
repayment of employee promissory note collateralized by common stock
acquisition cash consideration not yet paid
additions of property and equipment included in accrued expenses

We provide you with 20 years of cash flow statements for Blend Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Blend Labs stock. Explore the full financial landscape of Blend Labs stock with our expertly curated income statements.

The information provided in this report about Blend Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.